Critical Care Transesophageal Echocardiography in Patients during the COVID-19 Pandemic
Copyright © 2020 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved..
BACKGROUND: The COVID-19 pandemic has placed an extraordinary strain on healthcare systems across North America. Defining the optimal approach for managing a critically ill COVID-19 patient is rapidly changing. Goal-directed transesophageal echocardiography (TEE) is frequently used by physicians caring for intubated critically ill patients as a reliable imaging modality that is well suited to answer questions at bedside.
METHODS: A multidisciplinary (intensive care, critical care cardiology, and emergency medicine) group of experts in point-of-care echocardiography and TEE from the United States and Canada convened to review the available evidence, share experiences, and produce a consensus statement aiming to provide clinicians with a framework to maximize the safety of patients and healthcare providers when considering focused point-of-care TEE in critically ill patients during the COVID-19 pandemic.
RESULTS: Although transthoracic echocardiography can provide the information needed in most patients, there are specific scenarios in which TEE represents the modality of choice. TEE provides acute care clinicians with a goal-directed framework to guide clinical care and represents an ideal modality to evaluate hemodynamic instability during prone ventilation, perform serial evaluations of the lungs, support cardiac arrest resuscitation, and guide veno-venous ECMO cannulation. To aid other clinicians in performing TEE during the COVID-19 pandemic, we describe a set of principles and practical aspects for performing examinations with a focus on the logistics, personnel, and equipment required before, during, and after an examination.
CONCLUSIONS: In the right clinical scenario, TEE is a tool that can provide the information needed to deliver the best and safest possible care for the critically ill patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography - 33(2020), 8 vom: 01. Aug., Seite 1040-1047 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Teran, Felipe [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 31.08.2020 Date Revised 11.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.echo.2020.05.022 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311788114 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311788114 | ||
| 003 | DE-627 | ||
| 005 | 20231225143015.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.echo.2020.05.022 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1039.xml |
| 035 | |a (DE-627)NLM311788114 | ||
| 035 | |a (NLM)32600742 | ||
| 035 | |a (PII)S0894-7317(20)30329-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Teran, Felipe |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Critical Care Transesophageal Echocardiography in Patients during the COVID-19 Pandemic |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.08.2020 | ||
| 500 | |a Date Revised 11.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: The COVID-19 pandemic has placed an extraordinary strain on healthcare systems across North America. Defining the optimal approach for managing a critically ill COVID-19 patient is rapidly changing. Goal-directed transesophageal echocardiography (TEE) is frequently used by physicians caring for intubated critically ill patients as a reliable imaging modality that is well suited to answer questions at bedside | ||
| 520 | |a METHODS: A multidisciplinary (intensive care, critical care cardiology, and emergency medicine) group of experts in point-of-care echocardiography and TEE from the United States and Canada convened to review the available evidence, share experiences, and produce a consensus statement aiming to provide clinicians with a framework to maximize the safety of patients and healthcare providers when considering focused point-of-care TEE in critically ill patients during the COVID-19 pandemic | ||
| 520 | |a RESULTS: Although transthoracic echocardiography can provide the information needed in most patients, there are specific scenarios in which TEE represents the modality of choice. TEE provides acute care clinicians with a goal-directed framework to guide clinical care and represents an ideal modality to evaluate hemodynamic instability during prone ventilation, perform serial evaluations of the lungs, support cardiac arrest resuscitation, and guide veno-venous ECMO cannulation. To aid other clinicians in performing TEE during the COVID-19 pandemic, we describe a set of principles and practical aspects for performing examinations with a focus on the logistics, personnel, and equipment required before, during, and after an examination | ||
| 520 | |a CONCLUSIONS: In the right clinical scenario, TEE is a tool that can provide the information needed to deliver the best and safest possible care for the critically ill patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Acute respiratory syndrome associated with COVID-19 | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Novel coronavirus | |
| 650 | 4 | |a Point-of-care ultrasound | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Transesophageal echocardiography | |
| 700 | 1 | |a Burns, Katharine M |e verfasserin |4 aut | |
| 700 | 1 | |a Narasimhan, Mangala |e verfasserin |4 aut | |
| 700 | 1 | |a Goffi, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Mohabir, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Horowitz, James M |e verfasserin |4 aut | |
| 700 | 1 | |a Yuriditsky, Eugene |e verfasserin |4 aut | |
| 700 | 1 | |a Nagdev, Arun |e verfasserin |4 aut | |
| 700 | 1 | |a Panebianco, Nova |e verfasserin |4 aut | |
| 700 | 1 | |a Chin, Eric J |e verfasserin |4 aut | |
| 700 | 1 | |a Gottlieb, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Koenig, Seth |e verfasserin |4 aut | |
| 700 | 1 | |a Arntfield, Robert |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography |d 1995 |g 33(2020), 8 vom: 01. Aug., Seite 1040-1047 |w (DE-627)NLM013082469 |x 1097-6795 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2020 |g number:8 |g day:01 |g month:08 |g pages:1040-1047 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.echo.2020.05.022 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2020 |e 8 |b 01 |c 08 |h 1040-1047 | ||